Category Archives: Health

What is new in the field of Health. Trending topics, and cutting edge research in the are of Health. Press Releases that give us updates on Health.

HighOnLove’s New Sensual Massage Candle Brings Luxury and Romance to The Bedroom


News Image

It’s our vision at HighOnLove to break down barriers and eliminate taboos that surround self-pleasure.

HighOnLove™ is here to elevate your sexual experience. The brand is adding a Sensual Massage Candle to their line of superior grade sexual wellness products made with cannabis oil. Curated by Angela Mustone, a specialist producer of adult cosmetics, HighOnLove™ looks to provide the perfect second or third party to each users’ sexual experience while elevating their interior decor.

Spice up your room, turn up the heat and set the mood for a sensual massage with this luxurious , soy based candle blended with nourishing cannabis seed oil and coconut oil. The alluring scent of rose bud seduces your senses, while the sensation of warm oils against your skin encourages relaxation, loving exploration and romance.

“It’s our vision at HighOnLove to break down barriers and eliminate taboos that surround self-pleasure,” says Angela Mustone, founder and CEO of HighOnLove. “I wish for our future to continue our movement and help women embrace their sensuality and explore a deeper romance while pampering their skin and creating more elegant room decor.”

Using premier grade cannabis oil and nutrient-rich ingredients from the highest quality international suppliers, HighOnLove™ is alchemy at its finest. Angela has travelled extensively across many continents to test ingredients for her groundbreaking product line. Influenced by the world’s premium cosmeticians, these skin-friendly formulas provide revolutionary intimate experiences and a level of stimulation only cannabis oil can provide.

HighOnLove™ products are gynaecologically tested, chemical-free, vegan, and cruelty free. Made in Canada with premium, 100% natural ingredients, HighOnLove™ products contain no soap, parabens, allergens or colorants. Two versions of the line will be made available; the THC + CBD line and the Cannabis Seed Oil line to cater to those who live in areas with cannabis restrictions.

HighOnLove™ is available on http://www.highonlove.ca and ranges from $28 – $50 for their full 6-piece product line.

# # #

EDITOR’S NOTE: For more information on HighOnLove or to arrange to speak with a company spokesperson, please contact Nancy Trent or Pamela Wadler at 212-966-0024 or pam@trentandcompany.com.

Share article on social media or email:

Mosquito Activity Tracker Available for North Georgia Residents


Mr. Mister Mosquito Control Logo

“The Mosquito Activity Tracker uses weather and other environmental data to predict daily levels of mosquito activity, allowing Atlanta-area residents to avoid the worst of the mosquito swarming season,” Matt Brill, Co-owner, Mr. Mister.

According to the Georgia Department of Public Health, mosquito-borne viruses are most active late spring through early fall. Compounding the issue is the warm, wet winter Georgia experiences which has given way to an equally rainy spring, creating the ideal breeding conditions for mosquito populations.

This year’s peak season finds residents at home, using their yards more than ever. With this in mind, Mr. Mister Mosquito Control is introducing a Mosquito Activity Tracker on their website to allow area residents to plan well and protect their families. This is particularly relevant as Atlanta has once again been ranked as the number one city for mosquito activity in the US for the seventh year in a row!

“Mosquitoes are out in force this year, and we want Atlanta residents to have the latest information on their activity.” said Matt Brill, co-owner of Mr. Mister. “The Mosquito Activity Tracker uses weather and other environmental data to predict daily levels of mosquito activity, allowing Atlanta-area residents to avoid the worst of the mosquito swarming season.”

With over 700 5-Star reviews from customers, Mr. Mister is a leader in mosquito control in the Atlanta area. Their biodegradable solutions are backed by a 100% satisfaction guarantee. More information about Mr. Mister’s full range of mosquito control services as well as the daily Mosquito Activity Tracker are available at mrmr.biz.

About Mr. Mister Mosquito Control

Mr. Mister Mosquito Control, a locally owned and certified mosquito control company, provides North Georgia with residential and community services: mosquito control systems, mosquito spray services, and mosquito yard treatment. Mr. Mister serves more clients than any other company in Georgia and have more (and higher) ratings than any other company!

Our top-of-the-line mosquito control solutions will repel and remove the pests that are invading your home or backyard by up to 90 percent.We customize protection based on your needs and offer both ClearZone Misting Treatments and Automated Mosquito Control Systems in and around North Georgia.

More information is available at mrmr.biz or by connecting with Mr. Mister on Twitter @mrmosquitoatl, Facebook @MrMisterMosquitoControl, YouTube @Mr. Mister Mosquito Control and Instagram @mrmisteratl.

Share article on social media or email:



Foot doctor Tomasz Biernacki discusses the role of the podiatrists at Advanced Foot & Ankle Specialists of Pinckney, MI while supporting the COVID-19 response


Pinckney Michigan Podiatris: Dr. Tom Biernacki Foot & Ankle Surgeon

Dr. Tom Biernacki Foot & Ankle Surgeon

“For any patients who still have any foot ankle or leg wounds, ingrown toenails, or infections, you are still able to come in and see us. The goal is to keep as many people out of the hospital where the risk for infection can be much higher.”

The podiatrists and foot doctors of Advanced Foot & Ankle Specialists of Pinckney Michigan are helping flatten the Covid-19 curve and Howell Michigan, Brighton Michigan, and Ann Arbor Michigan. Dr. Tomasz Biernacki states that “Podiatrists can help support the hospital system by seeing all high-risk patients within the clinic and at the hospital.” General non-emergency patients will gradually become rescheduled on a full-time basis increasing on May 15th 2020 and then again June 1st 2020.

Dr. Tomasz Biernacki states “we are still seeing all wound and foot infection patients in the hospital, while at the same time trying to keep them from coming into the hospital in the first place. We are still continuing to see patients in the clinic.”

Dr. Biernacki further says “For any patients who still have any foot ankle or leg wounds, ingrown toenails or infections, you are still able to come in and see us. The goal is to keep as many people out of the hospital where the risk for infection can be much higher.”

Dr. Tomasz Biernacki is a practicing podiatric foot and ankle surgeon at Advanced Foot and Ankle specialists of Howell Michigan and Brighton Michigan.

Advanced foot and ankle specialists of Howell Michigan and Brighton Michigan pride themselves on providing comprehensive the care and working as a multispecialty team. The four doctors at this practice are on staff at St. Joseph Mercy Hospital Livingston, St. Joseph Mercy Hospital Brighton, and St. Joseph Mercy Hospital Ann Arbor. Working as part of this large multidisciplined team, they can work with internal medicine doctors, primary care doctors, endocrinologists and vascular surgery specialist to provide comprehensive care.

Advanced foot and ankle specialists have four different doctors within their practice: Dr. Tom Biernacki, Dr. John Stevelinck, Dr. Marc Bonanni and Dr. Danielle Meyka-Blanchard. All podiatrists foot doctors are on staff at St. Joseph Mercy hospitals in Ann Arbor, Howell and Brighton Michigan. They pride themselves on serving Livingston County and Washtenaw County.

Share article on social media or email:

Herman Legal Group Gives Back to Undocumented Essential Workers on the Frontlines of COID-19: $1,000 Essay Contest


undocumented, immigrants, immigration, reform, essential workers, DACA, COVID-19

$1,000 Essay Contest for Undocumented Essential Workers

What do YOU think of when you hear the word ‘IMMIGRANT’?

In an effort to encourage greater appreciation for undocumented immigrant workers, many of whom are valiantly working on the frontlines of COVID-19 in critical industries such as healthcare and food distribution, the Herman Legal Group is sponsoring a $1,000 Essay Contest.

Applicants must be an undocumented immigrant, which includes DACA recipients (“Dreamers”), and write an essay of at least 300 words, in any language, answering this question:

“What do you think of when you hear the word ‘IMMIGRANT’?”

Why the Essay Contest? Why Now? The United States is facing the most challenging healthcare and economic crises in 100 years. The pandemic impacts everyone. Undocumented immigrants are especially vulnerable. U.S. policy on immigration has increasingly become more aggressive and unwelcoming to immigrants. Despite the data to the contrary, many people now believe that immigrants undermine the U.S. economy and do not make the nation stronger.

As immigration attorneys, the Herman Legal Group understands the moral and economic imperative to support undocumented immigrants, particularly those who are working to keep everyone safe and healthy. Undocumented workers are often toiling in high-risk conditions of virus transmission, unprotected by any Personal Protection Equipment, and are getting sick.

Yet, despite their important contributions to the United States, including paying taxes, most undocumented workers (and even some U.S. citizen spouses) are not eligible to receive stimulus checks from the Federal Government, and their families are disproportionately feeling the devastating impact of the shutdown of the economy. Even during this pandemic, the undocumented population continues to be vilified and face the prospect of arrest, detention, deportation, and permanent separation from their U.S. citizen children.

The Herman Legal Group hopes that this contest inspires members of the undocumented community, at this unique moment in history, to share their personal feelings about being an immigrant who contributes to the well-being of the United States, who has deep ties to the United States, who may have U.S. citizen children or other family members, and yet has no legal pathway to normalize their immigration status.***

The Herman Legal Group will publish the winning essay on its website and will keep the winner’s identity confidential unless otherwise authorized by the winner. The law firm will also be publishing some of the non-winning essays in order to help give voice to the undocumented, to help stimulate a healthier conversation in the U.S. about immigration, and to encourage elected officials to move on legislation that would provide an earned pathway to permanent residency, and ultimately citizenship, to the undocumented.

For these reasons, we are honored to sponsor the “What Do YOU Think of When You Hear the Word ‘IMMIGRANT’?” Essay Contest.

Eligibility Requirements:

  • Applicant must be undocumented
  • Must be working, or have recently worked, as an essential worker in the healthcare industry, food supply, or other essential industries

How to Apply:

People who wish to participate should send their essay as an attachment in an email to ImmigrantStrongUSA@gmail.com by August 1, 2020.

In the body of the email, applicants should include the following information:

  • Your name, address, and phone number
  • If you are under 18, contact information for your parents
  • The nature of your job and length of employment
  • The best way to contact you

Once the application period has ended, our essay committee will review the essays and choose a winner by September 1, 2020. The winner will receive $1,000.

The winner will be chosen considering the following factors:

  • Originality
  • Responsiveness to the question asked
  • The quality of the writing
  • The substantive content of the response

By applying, all applicants consent to the reproduction and publishing of their essays. Name and other contact information shall always remain confidential. Follow this link for more information on the “What Do YOU Think of When You Hear the Word ‘IMMIGRANT’?” Essay Contest.    

#ImmigrantStrong

Footnotes

*In 2018, there were almost 280,000 undocumented workers in the healthcare industry, including 62,600 DACA-eligible individuals. New American Economy.

**3.8 million Immigrants make up more than one in five workers in the U.S. food sector. They are among the essential workers who leave the safety of their homes to handpick fresh vegetables and fruits, processed meat and seafood, stock shelves with groceries, and deliver food to people’s doorsteps. New American Economy.

***There are anywhere from 12 to 20 million undocumented immigrants in the U.S., many of whom have been here for than a decade, have U.S. citizen children and spouse, and run their own businesses. The LIFE Act, which provided a pathway to citizenship for undocumented immigrants, expired on April 30, 2001.

Contact the Herman Legal Group for More Information

Founded in 1995, the Herman Legal Group focuses on immigration law, including family immigration, removal defense, employment-based immigration, investor immigration, asylum, immigration waivers. We are headquartered in Cleveland, Ohio, and have additional offices in Columbus, Columbus, Cincinnati, Dayton, Toledo, Detroit, Buffalo, Pittsburgh, Charlotte, Miami, and Dallas. The firm’s immigration lawyers serve clients in over 12 languages and in all 50 states. For over 25 years, the Herman Legal Group has earned the reputation of highly-skilled, compassionate, and innovative immigration lawyers. To contact the firm, call 1-800-808-4013

About the Founder of Herman Legal Group

Richard Herman is a nationally renowned immigration lawyer. As a lawyer, activist, author and speaker, he has dedicated his life to advocating for immigrants and helping change the conversation on immigration. He is the co-author of the acclaimed book, Immigrant, Inc. —Why Immigrant Entrepreneurs Are Driving the New Economy (And How They Will Save the American Worker) (John Wiley & Sons, 2009). Richard is one of the pioneers of the movement by Midwest cities to attract and welcome immigrants who can help grow the economy, create jobs and reverse progressive depopulation. He regularly advises cities and counties on innovative ways to leverage existing immigration law to create jobs and attract foreign direct investment.

Voted for inclusion in the 2015-2020 editions of The Best Lawyers in America© and listed in Super Lawyers© for more than fourteen consecutive years, Richard began his immigration law career by moving to Moscow, Russia in 1993, straight out of law school, to eventually open a law office two blocks from the Kremlin to represent post-Soviet entrepreneurs. As an authority on U.S. immigration law and a provocateur for immigrant-friendly, pro-entrepreneur policies, Richard is often invited to strategize and deliver keynote addresses around the country, as he has often done for Michael Bloomberg and Rupert Murdoch’s Partnership for a New American Economy, chambers of commerce, universities and cities. Known for his direct and sometimes controversial style, Richard has appeared on FOX News (The O’Reilly Factor), National Public Radio, and has appeared in the New York Times, USA Today, BusinessWeek, Forbes, Inc., PC World, Computerworld, CIO, TechCrunch and InformationWeek. Richard is married to Kimberly Chen, an immigrant from Taiwan who overcame her undocumented status to become an American physician. They live in the Cleveland area with their two children, whom they are raising to be citizens of the world.

Podiatrist & Foot Doctor Tomasz Biernacki Discusses Ingrown Toenail and Nail Fungus Options at Advanced Foot & Ankle Specialists of Howell Michigan.


Dr. Tomasz Biernacki Foot & Ankle Surgeon discusses medical pedicure treatment and ingrown toenail surgery!

Dr. Tomasz Biernacki Foot & Ankle Surgeon discusses medical pedicure treatment and ingrown toenail surgery!

“We are so thankful to be your choice for ingrown toenails and toenail infections! Our number one goal is to take great care of people’s foot and ankle problems for as little cost as possible.

Dr. Tomasz Biernacki states “Many people wait a little too long for their ingrown toenails to get seen. Sometimes until an infection develops as well as a large wound that can take a month or more to heal! It is important to come in early before the problem gets bad!”    

Advanced foot and ankle specialists of Howell Michigan and Brighton Michigan have been performing removal of ingrown toenails, infected toenails and medical pedicures for toenail fungus for over 20+ years in Livingston County. This podiatrist and foot doctor practice includes four hospital trained podiatrists and ingrown toenail removal specialists available to help with the full range of toenail problems.

Ingrown Toenail Removal Options:

There are three types of ingrown toenail removal that are routinely performed.

1)Podiatrist Performed Medical Pedicure:

  •     A medical pedicure consists of using specialized sterile instruments are used for cleaning and shortening thick and fungal toenails.
  •     The next step is maintaining proper moisturizing of a patient’s feet. The patient is evaluated for any decreased blood flow, any nerve disorders, any skin disorders.
  •     This is not a cosmetic medical pedicure excavation point. This is specifically based on medical standards.

2) Podiatrist Performed Ingrown Toenail Removal Treatment:

  • To remove an ingrown toenail to the root, it would be necessary to use local anesthetic to avoid feeling pain.
  • If there is infection present, a wound culture can be taken to make sure there were not any abnormal bacteria growing.
  • If there are signs of significant infection, an antibiotic can be offered.

3) Podiatrist Performed Permanent Ingrown Toenail Removal:

  • Another name for this is a total matrixectomy.
  • If an ingrown toenail comes back more than 2-3x times, it may be worth it to apply medication to the root of the removed toenail.
  • This is much less likely to allow the toenail to ever go back.
  • Once this is performed, it is very unlikely for a nail to come back soon.


Advanced foot and ankle specialists of Howell Michigan and Brighton Michigan pride themselves on providing comprehensive the care and working as a multispecialty team. The four doctors at this practice are on staff at St. Joseph Mercy Hospital Livingston, St. Joseph Mercy Hospital Brighton, and St. Joseph Mercy Hospital Ann Arbor. Working as part of this large multidisciplined team, they can work with internal medicine doctors, primary care doctors, endocrinologists and vascular surgery specialist to provide comprehensive care.

Advanced foot and ankle specialists have four different doctors within their practice: Dr. Tom Biernacki, Dr. John Stevelinck, Dr. Marc Bonanni and Dr. Danielle Meyka-Blanchard. All four of our foot doctors are on staff at St. Joseph Mercy hospitals. They pride themselves on serving Livingston County and Washtenaw County.

In the past podiatrists were simply office-based clinicians, but now are all medical school and residency trained physicians. All four doctors at Advanced Foot & Ankle Specialists have spent four years of medical school, and at least three years in a hospital-based surgical residency. Now the podiatrists of Advanced Foot & Ankle Specialists boast Harvard residency status, and some have received post residency specialized fellowship training in diabetic surgery and wound care.

Dr. Tom Biernacki states “We are so thankful to be your choice for ingrown toenails and toenail infections! Our number one goal is to take great care of people’s foot and ankle problems, with as little surgery as possible, and for as little cost as possible. We emphasize getting people better as quickly as possible, and it looks like we are starting to really make a difference!”

Share article on social media or email:

Talos Health Solutions Offers Information to Help Asthma Sufferers During Covid-19


older woman clutching her chest

With the importance of world Asthma Day on May 5th and the current Covid-19 pandemic, I strongly encourage those suffering from asthma and their caregivers to participate in AsthmaCon. It is a very information-rich online conference.

Talos Health Solutions announces information to help asthma sufferers manage their disease during Covid-19. This information is now available at AsthmaCon, a free confidential virtual online health conference. Conference attendees can access this information online at http://www.asthmacon.com when visiting the booths for the Asthma & Allergy Network (AAN) and the Asthma and Allergy Foundation of America (AAFA). Asthma patients and care givers are invited to participate in AsthmaCon that runs through June 30, 2020.

AsthmaCon attendees will also find several video presentations from respiratory experts and asthma patients as they speak on various topics. Video presentations include how to create and follow an asthma action plan, how to recognize severe asthma, how to use technology to manage your asthma and many others.

Those participating in AsthmaCon and watching the conference videos will hear from global respiratory experts including Dr. Tim Harrison with the Division of Respiratory Medicine at the University of Nottingham UK, Dr. Andrew Menzies-Gow, the Director of Lung Division and consultant respiratory physician at the Royal Brompton Hospital in London, Dr. Stephanie Christenson, MD with the Division of Pulmonary, Critical Care, Allergy and Sleep Medicine from the University of California San Francisco and several other experts. Topics presented in conference videos include how to use technology to manage your asthma, recognizing asthma symptoms, identifying exacerbations, recognizing severe asthma, understanding your numbers for lung function, lung nitric oxide, blood cell counts and blood oxygen. There are over 20 video presentations conference attendees can watch throughout the duration of AsthmaCon which ends on June 30, 2020.

Patient expert Mitchell Silva stated, “The integration of video within AsthmaCon makes the entire conference exceptionally interactive. Attendees have the flexibility to watch the video presentations at their own pace throughout the duration of the conference. A good variety of topics are featured from different experts including medical professionals, patient advocate groups and asthmatic patients themselves. With the importance of world Asthma Day on May 5th and the current Covid-19 pandemic, I strongly encourage those suffering from asthma and their caregivers to participate in AsthmaCon. It is a very information-rich online conference.”

Talos Health Solutions launched AsthmaCon on March 27, 2020. This three-month online educational health conference is geared to helping people with asthma, their families and caregivers living in the US. AsthmaCon is a free online conference available 24-hours a day through June 30, 2020.

AsthmaCon 2020 is an AstraZeneca Pharmaceuticals initiative in partnership with The American Allergy and Asthma Network (AAN), the Global Allergy and Asthma Patient Platform (GAAP), the Asthma and Allergy Foundation of America and Talos Health Systems.

For more information on conference videos or participating in AsthmaCon, visit online at: http://www.asthmacon.com.

Share article on social media or email:

Why using current sanitation efforts will create more deadly superbugs – Betterair may be the solution


News Image

“We have to get away from the idea of annihilating these things in our local environment. It just plays upon fear.”

Even prior to the current health crisis, on average Americans spent as much as 90% of their time indoors. According to EPA studies, indoor air can be up to five times more polluted than outdoor air, exposing us to harmful organisms that make us sick and can weaken our immune systems. The CDC states 80% of all infectious diseases are transmitted by touch, underlying the need to ensure our surfaces and objects are free from the threat of these harmful pathogens as well. Betterair has designed solutions to resolve these problems that naturally clean your indoor air as well as surfaces.    

One of the reasons our indoor environment is more unsafe is our over reliance on cleaning products and their claims to kill 99% of germs. In addition to killing germs, these products are killing good bacteria, which are necessary for healthy living. According to Dr. Keiji Fukuda in The New York Times, “We have to get away from the idea of annihilating these things in our local environment. It just plays upon fear.”

In fact, our overuse of chemical and artificial cleaners is creating superbugs that are resistant to current medicine. The more we sterilize, the more we will create superbugs that will result in deadlier pandemics. Scientific American warned of this potential development more than a decade ago, but we have continued in our overuse of these products and sterilization methods. This causes our immune system to weaken because we need to interact with nature and her natural occurring bacteria. According to Dr. Meg Lemon, in The New York Times, “Our immune system needs a job. We evolved over millions of years to have our immune systems under constant assault. Now they have nothing to do.”

It is essential we minimize our use of these cleansing products and balance our indoor ecology so that good bacteria can flourish while bad bacteria can be controlled. Betterair’s all-natural probiotic process removes the allergens, mold, and pathogens in the air and on surfaces without using synthetic means that can create superbugs. Betterair’s probiotics balance the indoor ecology, eliminating the threat these organisms pose. While other purifiers kill the good bacteria along with the bad, Betterair does not. Plus Betterair is safe, simple, and filter less.

Betterair provides ecological restoration indoors through patented, automated systems that disperse environmental probiotics into the air and on surfaces. The result is the reduction of illnesses, breathing disorders, allergic reactions and other pollutant-based ailments that are caused by these toxins. It’s time for us to work with Nature, not against it.

For more on Betterair, visit betterairus.com and follow on Facebook, Twitter, Instagram, and YouTube

###

EDITOR’S NOTE: For more information about Betterair and to arrange to speak with a company spokesperson, please contact Nancy Trent or Pamela Wadler at 212-966-0024 or pam@trentandcompany.com.

Share article on social media or email:

NeoTract Designates Dr. Keith Waguespack as UroLift® Center of Excellence


News Image

“This designation recognizes Dr. Keith Waguespack as a UroLift Center of Excellence for his commitment to providing safe and effective treatment to patients with BPH,” said Dave Amerson

NeoTract, a wholly owned subsidiary of Teleflex Incorporated (NYSE:TFX) focused on addressing unmet needs in the field of urology, today announced that Keith Waguespack M.D., Urology Partners of North Texas in Irving, TX, has been designated as a UroLift® Center of Excellence. The designation recognizes that Dr. Waguespack has achieved a high level of training and experience with the UroLift® System and demonstrated a commitment to exemplary care for men suffering from symptoms associated with Benign Prostatic Hyperplasia (BPH), also known as enlarged prostate.

Recommended for the treatment of BPH in both the American Urological Association and European Association of Urology clinical guidelines, the FDA-cleared Prostatic Urethral Lift procedure using the UroLift System is a proven, minimally invasive technology for treating lower urinary tract symptoms due to BPH. The UroLift permanent implants, delivered during a transurethral outpatient procedure, relieve prostate obstruction and open the urethra directly without cutting, heating, or removing prostate tissue.

The UroLift Center of Excellence program is designed to highlight urologists who are committed to educating their patients on BPH and the UroLift System as a treatment option and consistently seek to deliver excellent patient outcomes and experiences.

“This designation recognizes Dr. Keith Waguespack as a UroLift Center of Excellence for his commitment to providing safe and effective treatment to patients with BPH,” said Dave Amerson, president of the Teleflex Interventional Urology business unit. “We are pleased to see the continued acceptance of the UroLift System as a standard of care treatment that may allow men to discontinue the use of BPH medications and improve their quality of life.”

Over 40 million men in the United States are affected by BPH, a condition that occurs when the prostate gland that surrounds the male urethra becomes enlarged with advancing age and begins to obstruct the urinary system. Symptoms of BPH often include interrupted sleep and urinary problems and can cause loss of productivity, depression and decreased quality of life.

Medication is often the first-line therapy for enlarged prostate, but relief can be inadequate and temporary. Side effects of medication treatment can include sexual dysfunction, dizziness and headaches, prompting many patients to quit using the drugs. For these patients, the classic alternative is surgery that cuts, heats or removes prostate tissue to open the blocked urethra. While current surgical options can be very effective in relieving symptoms, they can also leave patients with permanent side effects such as urinary incontinence, erectile dysfunction, and retrograde ejaculation.

About the UroLift® System

The FDA-cleared UroLift System is a proven, minimally invasive technology for treating lower urinary tract symptoms due to benign prostatic hyperplasia (BPH). The UroLift permanent implants, delivered during a minimally invasive transurethral outpatient procedure, relieve prostate obstruction and open the urethra directly without cutting, heating, or removing prostate tissue. Clinical data from a pivotal 206-patient randomized controlled study showed that patients with enlarged prostate receiving UroLift implants reported rapid and durable symptomatic and urinary flow rate improvement without compromising sexual function*1,2. Patients also experienced a significant improvement in quality of life. Over 100,000 men have been treated with the UroLift System in the U.S. Most common adverse events reported include hematuria, dysuria, micturition urgency, pelvic pain, and urge incontinence. Most symptoms were mild to moderate in severity and resolved within two to four weeks after the procedure. The Prostatic Urethral Lift procedure using the UroLift System is recommended for the treatment of BPH in both the American Urological Association and European Association of Urology clinical guidelines. The UroLift System is available in the U.S., Europe, Australia, Canada, Mexico and South Korea. Learn more at http://www.UroLift.com.

About NeoTract | Teleflex Interventional Urology

A wholly owned subsidiary of Teleflex Incorporated, the Interventional Urology Business Unit is dedicated to developing innovative, minimally invasive and clinically effective devices that address unmet needs in the field of urology. Our initial focus is on improving the standard of care for patients with BPH using the UroLift System, a minimally invasive permanent implant system that treats symptoms while preserving normal sexual function*1,2. Learn more at http://www.NeoTract.com.

About Teleflex Incorporated

Teleflex is a global provider of medical technologies designed to improve the health and quality of people’s lives. We apply purpose driven innovation – a relentless pursuit of identifying unmet clinical needs – to benefit patients and healthcare providers. Our portfolio is diverse, with solutions in the fields of vascular and interventional access, surgical, anesthesia, cardiac care, urology, emergency medicine and respiratory care. Teleflex employees worldwide are united in the understanding that what we do every day makes a difference. For more information, please visit http://www.teleflex.com.

Teleflex is the home of Arrow®, Deknatel®, Hudson RCI®, LMA®, Pilling®, Rusch®, UroLift® and Weck® – trusted brands united by a common sense of purpose

For Teleflex Incorporated:

Jake Elguicze, 610.948.2836

Treasurer and Vice President, Investor Relations

Media:

Nicole Osmer, 650.454.0504 nicole@healthandcommerce.com

*No instances of new, sustained erectile or ejaculatory dysfunction

1. Roehrborn, J Urology 2013 LIFT Study

2.McVary, J Sex Med 2016

MAC00968-01 Rev A

Share article on social media or email:

Enquire Releases Senior Living COVID-19 Statistics for April


We have seen several surveys and opinions about the impact COVID-19 is having on senior living sales and marketing, but it is important to look at the data and what it is telling us, states Erin Hayes, Enquire Chief Revenue Officer.

Enquire, a leading provider of CRM, marketing automation and contact center solutions for senior living communities and post-acute care organizations, has aggregated actual sales and marketing data from over 2,200 senior living communities providing insight into the true impact of COVID-19. In this report, 2020 averages for specific metrics by care level, state and region as well as year-to-date metrics were compared to the same period in 2019. This data was also narrowed to the just-completed month of April and analyzed against the same data points from April 2019. The report focuses on the average inquiry, tour and move in volume month-over-month per community and compares 2019 trends to 2020. Additionally, the report looks at other key sales and marketing metrics like web forms from internet inquiries, home visits, call outs, referrals and move outs that are critical to senior living sales and marketing success.

“We have seen several surveys and opinions about the impact COVID-19 is having on senior living sales and marketing, but it is important to look at the data and what it is telling us. We all could have predicted that inquiries, tours and move ins would be negatively impacted by COVID-19, so the real questions will be how great is the impact and for how long? This is what having this data will help us understand,” states Erin Hayes, Enquire Chief Revenue Officer.

These data points will continue to give owners, operators and the investment community insight into what a recovery will look like and how the effects on changing operations, consumer confidence and financial outlook will impact move ins, move outs and overall occupancy trends.

Senior Living COVID-19 Statistics:

  • Although communities have experienced a 22% decrease in move ins, they have also had less move outs, averaging a 15% decrease year-to-date.
  • Across all levels of care, year-to-date initial tours were down an average of 27% (total tours decreased 29%) due to most communities suspending onsite tours.
  • Home visits have increased on average 39% for the month of April 2020 in comparison to April 2019.
  • Communities supported by a contact center saw just over 20% more inquiries on average and held over 30% more initial tours in 2019 and are trending the same for 2020.
  • The South Central region is the least affected in April by COVID-19 with nominal decreases across the board in comparison to other regions.
  • Communities that have an integrated CRM and marketing automation strategy experienced 10% higher inquiries in 2019 and 16% higher inquiries year-to-date 2020 than those that do not.
  • Communities offering assisted living and memory care saw over a 20% increase in inquiries, tours and move ins for January and February over the same period in 2019.


This report will be updated monthly as Enquire continues to aggregate critical data to inform senior living sales and marketing teams. The full April report can be accessed here: https://enquiresolutions.com/senior_living_covid_19_statistics_april_2020/

ABOUT ENQUIRE

Enquire is the premier CRM, marketing automation and contact center solution provider in senior living and post-acute care. Headquartered in Denver, Colorado, Enquire serves senior living communities and healthcare facilities throughout the United States and Canada. Enquire’s vision is to improve the experience for prospects and family members through customer service centric products paired with cutting-edge technology and analytics.

Share article on social media or email:

Saisei Pharma plans clinical study of oral MAF in COVID-19 patients


our innate immunity can fight off pathogens without causing inflammation and associated respiratory deterioration

Saisei Pharma today announced plans to initiate an international clinical trial. The decision is based on published preclinical evidence, preliminary reports from independent studies and is supported by data of the safety and efficacy of oral MAF in conditions that require the involvement of macrophages as the front line defense in innate immunity. Prior studies have indicated that oral MAF can activate macrophage activity at least three-fold within a few minutes after application. This outstanding phenomenon could play an important role in deploying rapid innate immune response against SARS-CoV-2. The MAF induced phagocytosis enhances antigen processing and their presentation to effector lymphocytes, which is critical in forming the adequate adaptive immune response and synthesis specific antiviral antibodies [1-4]. Enhanced phagocytosis of SARS-CoV-2 viral particles and quicker effective innate and adaptive immune responses increase the probability of the abortive or shorter infection course. In addition to reduced viral load, MAF can downplay hyperactive proinflammatory response causing respiratory failure.

‘’The efficient innate immune response against SARS-CoV-2 is critical since there is no pre-existing immunity to exotic coronaviruses in humans who were not exposed to it earlier. The potent effect of Saisei Pharma MAF on phagocytosis is not accompanied by clinical or biochemical signs of inflammation when administered to humans. This means that our innate immunity can fight off pathogens without causing inflammation and associated respiratory deterioration” said immunologist Dr. Galyna Kutsyna, MD/PhD.

“Saisei Pharma is taking a number of steps to address the urgent need arising from the COVID-19 pandemic,” said Dr. Toshio Inui, MD, Head Global Drug Development and Chief Medical Officer. “The potential that oral MAF could lead to faster recovery for COVID-19 patients with fewer requiring intensive care and mechanical ventilation is encouraging and merits further investigation. While oral MAF is very safe, its safety and efficacy profile has not yet been established with regards to COVID-19.”

Given the global spread of the pandemic, and as plans for the study are being finalized, Saisei Pharma also has set up an international compassionate use program for eligible patients, subject to local approvals. In addition, steps are taken to manage the anticipated increase in COVID-19 related requests for oral MAF without interrupting access for patients taking oral MAF for its current indications. Saisei Pharma intends to join key industry partners against COVID-19 to complement the array of available therapy options. To support access, Saisei Pharma is committed to keeping stable prices for its range of products that may help in the treatment of COVID-19.

About Saisei Pharma oral MAF

Clinically active form of oral MAF is derived from enzyme-treated dairy products. MAF resulted from decades-long R&D activity by Saisei Pharma aimed at improving production technology and ensure the product’s higher activity and stability. The final goal is to make oral MAF available globally for conditions involving inadequate immune response due to macrophage dysfunction and hyper immune-inflammatory disorders in adult and pediatric patients. Saisei Pharma has filed a series of patents in Japan, EU, USA, and worldwide which relate to the technology, comprising the composition and method of production. Oral MAF is available as a health food or immunomodulating supplement in several countries, e.g., USA, Spain, Lithuania, and Ukraine. The exact indication for oral MAF varies by country. Additional worldwide regulatory filings are underway in other countries. Information about Saisei Pharma is available on the company website http://www.saisei-pharma.co.jp.

Saisei Pharma Global Media Relations

Contact: Mr. Martin Mette

Email: contact-sp@saisei-pharma.co.jp

Tel: +81-90-8823-0885

References

1. Sumiya Y, Ishikawa M, Inoue T, Inui T, Kuchiike D, Kubo K, Uto Y, Nishikata T. Macrophage activation mechanisms in human monocytic cell line-derived macrophages. Anticancer Res 2015;35:4447-51.

2. Ishikawa M, Mashiba R, Kawakatsu K, Tran NK, Nishikata T. (2018). A high-throughput quantitative assay system for macrophage phagocytic activity. Macrophage 2018;5:e1627.

3. Uto Y, Kawai T, Sasaki T, Hamada K, Yamada H, Kuchiike D, Kubo K, Inui T, Mette M, Tokunaga K, Hayakawa A, Go A, Oosaki T. Degalactosylated/desialylated bovine colostrum induces macrophage phagocytic activity independently of inflammatory cytokine production. Anticancer Res 2015;35:4487-92.

4. Mohamad SB, Hori H, Nagasawa H, Usui K, Uto Y. Characterization of human Gc protein-derived macrophage activation factor (GcMAF) and its functional role in macrophage tumoricidal activity. Adv Exp Med Biol. 2003;510:77‐82.

Disclaimer

This press release contains forward-looking statements regarding potential marketing approvals, new indications or labeling for oral MAF, regarding potential future revenues from such products, regarding our plans to initiate a clinical trial to evaluate the use of oral MAF in COVID-19 patients, or regarding the international compassionate use program for eligible patients. You should not place undue reliance on these statements. Such forward-looking statements are based on our current beliefs and expectations regarding future events and are subject to significant known and unknown risks and uncertainties. Should one or more of these risks or uncertainties materialize, or should underlying assumptions prove incorrect, actual results may vary materially from those set forth in the forward-looking statements. There is no guarantee that oral MAF will be submitted or approved for sale or for any additional indications or labeling in any market, or at any predetermined time. Neither can there be any guarantee that we will initiate the planned clinical trial in the expected time frame. Nor can there be any guarantee that oral MAF will meet the primary or secondary endpoints of the planned trial. Neither can there be any guarantee that oral MAF will be commercially successful in the future. Our expectations regarding Saisei products and the international compassionate use program could be affected by, among other things, the uncertainties inherent in research and development, including clinical trial results and additional analysis of existing clinical data; regulatory actions or delays or government regulation generally; global trends toward health care cost containment, including government, payor and general public pricing and reimbursement pressures and requirements for increased pricing transparency; our ability to obtain or maintain proprietary intellectual property protection; prescribing preferences of physicians and patients; general political, economic and business conditions, including the effects of and efforts to mitigate pandemic diseases such as COVID-19; safety, quality, data integrity or manufacturing issues; potential or actual data security and data privacy breaches, or disruptions of our information technology systems, and other risks and factors. Saisei Pharma is providing the information in this press release as of this date and does not undertake any obligation to update forward-looking statements contained in this press release as a result of new information, future events or otherwise.

Share article on social media or email: